Genentech Inc - Product Pipeline Analysis, 2016 Update

Date: December 30, 2016
Pages: 54
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G43534C97ABEN
Leaflet:

Download PDF Leaflet

Genentech Inc - Product Pipeline Analysis, 2016 Update
Summary

Genentech Inc (Genentech) is a biotech company that undertakes discovery, development, manufacture and commercialization of medicines for the treatment of patients with serious medical conditions. The company focuses on developing drugs for unmet medical needs in the areas of oncology, immunology, neuroscience, metabolism, infectious disease, ophthalmology and bioinformatics. Some of its products include Rituxan, Avastin, Herceptin, Tarceva, Lucentis, Xolair, Pulmozyme, Activase and others. Genentech research activities focus on areas of cancer, metabolism, immunology, infectious disease and neuroscience. Its clinical development pipeline includes small molecules, monoclonal antibodies, and antibody drug conjugates. The company operates as a wholly owned subsidiary of Roche. Genentech is headquartered in South San Francisco, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Genentech Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Genentech Inc Company Overview
Genentech Inc Company Snapshot
Genentech Inc Pipeline Products and Clinical Trials Overview
Genentech Inc – Pipeline Analysis Overview
Business Description
Key Facts
Genentech Inc - Major Products and Services
Genentech Inc Pipeline Products by Development Stage
Genentech Inc Pipeline Products Overview
Anti-HER3/EGFR DAF Mab Companion Diagnostic Assay
Anti-HER3/EGFR DAF Mab Companion Diagnostic Assay Product Overview
Anti-IL17 Mab Companion Diagnostic Assay
Anti-IL17 Mab Companion Diagnostic Assay Product Overview
Arbaclofen Companion Diagnostic Assay
Arbaclofen Companion Diagnostic Assay Product Overview
Atezolizumab Companion Diagnostic Assay
Atezolizumab Companion Diagnostic Assay Product Overview
Bevacizumab Companion Diagnostic Assay
Bevacizumab Companion Diagnostic Assay Product Overview
ChK1 Inhibitor - GDC-0575 Companion Diagnostic Assay
ChK1 Inhibitor - GDC-0575 Companion Diagnostic Assay Product Overview
Cobimetinib Companion Diagnostic Assay
Cobimetinib Companion Diagnostic Assay Product Overview
Crenezumab - Anti-Abeta Companion Diagnostic Assay
Crenezumab - Anti-Abeta Companion Diagnostic Assay Product Overview
ERK Inhibitor - Companion Diagnostic Assay
ERK Inhibitor - Companion Diagnostic Assay Product Overview
Erlotinib Companion Diagnostic Assay
Erlotinib Companion Diagnostic Assay Product Overview
Ipatasertib Companion Diagnostic Assay
Ipatasertib Companion Diagnostic Assay Product Overview
Lampalizumab - Anti-Factor D Fab Companion Diagnostic Assay
Lampalizumab - Anti-Factor D Fab Companion Diagnostic Assay Product Overview
Lebrikizumab Companion Diagnostic Assay
Lebrikizumab Companion Diagnostic Assay Product Overview
Lucentis PFS
Lucentis PFS Product Overview
Lucentis PFS Clinical Trial
MEK Inhibitor - GDC-0973 Companion Diagnostic Assay
MEK Inhibitor - GDC-0973 Companion Diagnostic Assay Product Overview
MEK Inhibitor - GDC-0623 Companion Diagnostic Assay
MEK Inhibitor - GDC-0623 Companion Diagnostic Assay Product Overview
Nav1.7 Inhibitor Companion Diagnostic Test
Nav1.7 Inhibitor Companion Diagnostic Test Product Overview
PI3 Kinase Inhibitor - GDC-0084 Companion Diagnostic Assay
PI3 Kinase Inhibitor - GDC-0084 Companion Diagnostic Assay Product Overview
PI3 Kinase Inhibitor - Taselisib Companion Diagnostic Assay
PI3 Kinase Inhibitor - Taselisib Companion Diagnostic Assay Product Overview
PI3 Kinase/mTOR Dual Inhibitor - GDC-0980 Companion Diagnostic Assay
PI3 Kinase/mTOR Dual Inhibitor - GDC-0980 Companion Diagnostic Assay Product Overview
Pictilisib - GDC-0941 Companion Diagnostic Assay
Pictilisib - GDC-0941 Companion Diagnostic Assay Product Overview
Quilizumab (Anti-M1 prime Mab) Companion Diagnostic Assay
Quilizumab (Anti-M1 prime Mab) Companion Diagnostic Assay Product Overview
Ranibizumab Companion Diagnostic Assay
Ranibizumab Companion Diagnostic Assay Product Overview
Tocilizumab Companion Diagnostic Assay
Tocilizumab Companion Diagnostic Assay Product Overview
Tofogliflozin Companion Diagnostic Assay
Tofogliflozin Companion Diagnostic Assay Product Overview
Vemurafenib Companion Diagnostic Assay - Thyroid Cancer
Vemurafenib Companion Diagnostic Assay - Thyroid Cancer Product Overview
Vismodegib Companion Diagnostic Assay
Vismodegib Companion Diagnostic Assay Product Overview
Genentech Inc - Key Competitors
Genentech Inc - Key Employees
Genentech Inc - Locations And Subsidiaries
Head Office
Recent Developments
Genentech Inc, Recent Developments
Oct 14, 2016: FDA Approves Genentech’s Lucentis (Ranibizumab Injection) Prefilled Syringe
May 05, 2016: Preliminary results comparing PD-L1 IHC diagnostic assays in lung cancer released
Jan 14, 2015: Human Longevity Signs Agreement with Genentech for Whole Genome Sequencing and Analysis of Samples
Apr 07, 2014: Genentech and PatientsLikeMe Enter Patient-Centric Research Collaboration
Feb 19, 2014: Cogent Reports Genentech Regains Its Dominance in Image Among Oncologists
Feb 03, 2014: PDL BioPharma Announces Agreement with Genentech and Roche to Settle Litigation and Arbitration
Oct 14, 2013: Genentech Announces Plans to Expand California Biologics Manufacturing Facilities
Jun 11, 2013: PDL BioPharma Files For Arbitration Against Genentech Based On Underpayment Of Royalties
Mar 05, 2013: Dako Receives FDA Approval For Two Assays As Companion Diagnostics For Genentech's New Breast Cancer Medicine Kadcyla
Feb 04, 2013: Vernalis Receives $1.5m Milestone Payment From Drug Discovery Collaboration With Genentech
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Genentech Inc Pipeline Products and Clinical Trials Overview
Genentech Inc Pipeline Products by Equipment Type
Genentech Inc Pipeline Products by Indication
Genentech Inc Clinical Trials by Trial Status
Genentech Inc, Key Facts
Genentech Inc, Major Products and Services
Genentech Inc Number of Pipeline Products by Development Stage
Genentech Inc Pipeline Products Summary by Development Stage
Genentech Inc Clinical Trials Summary
Anti-HER3/EGFR DAF Mab Companion Diagnostic Assay - Product Status
Anti-HER3/EGFR DAF Mab Companion Diagnostic Assay - Product Description
Anti-IL17 Mab Companion Diagnostic Assay - Product Status
Anti-IL17 Mab Companion Diagnostic Assay - Product Description
Arbaclofen Companion Diagnostic Assay - Product Status
Arbaclofen Companion Diagnostic Assay - Product Description
Atezolizumab Companion Diagnostic Assay - Product Status
Atezolizumab Companion Diagnostic Assay - Product Description
Bevacizumab Companion Diagnostic Assay - Product Status
Bevacizumab Companion Diagnostic Assay - Product Description
ChK1 Inhibitor - GDC-0575 Companion Diagnostic Assay - Product Status
ChK1 Inhibitor - GDC-0575 Companion Diagnostic Assay - Product Description
Cobimetinib Companion Diagnostic Assay - Product Status
Cobimetinib Companion Diagnostic Assay - Product Description
Crenezumab - Anti-Abeta Companion Diagnostic Assay - Product Status
Crenezumab - Anti-Abeta Companion Diagnostic Assay - Product Description
ERK Inhibitor - Companion Diagnostic Assay - Product Status
ERK Inhibitor - Companion Diagnostic Assay - Product Description
Erlotinib Companion Diagnostic Assay - Product Status
Erlotinib Companion Diagnostic Assay - Product Description
Ipatasertib Companion Diagnostic Assay - Product Status
Ipatasertib Companion Diagnostic Assay - Product Description
Lampalizumab - Anti-Factor D Fab Companion Diagnostic Assay - Product Status
Lampalizumab - Anti-Factor D Fab Companion Diagnostic Assay - Product Description
Lebrikizumab Companion Diagnostic Assay - Product Status
Lebrikizumab Companion Diagnostic Assay - Product Description
Lucentis PFS - Product Status
Lucentis PFS - Product Description
Lucentis PFS - A Phase I/II, Open Label, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of Intravitreal Injections of 0.3 mg Ranibizumab Given Monthly Compared to a TReat and EXtend Protocol in Patients with Diabetic Macular Edema
MEK Inhibitor - GDC-0973 Companion Diagnostic Assay - Product Status
MEK Inhibitor - GDC-0973 Companion Diagnostic Assay - Product Description
MEK Inhibitor - GDC-0623 Companion Diagnostic Assay - Product Status
MEK Inhibitor - GDC-0623 Companion Diagnostic Assay - Product Description
Nav1.7 Inhibitor Companion Diagnostic Test - Product Status
Nav1.7 Inhibitor Companion Diagnostic Test - Product Description
PI3 Kinase Inhibitor - GDC-0084 Companion Diagnostic Assay - Product Status
PI3 Kinase Inhibitor - GDC-0084 Companion Diagnostic Assay - Product Description
PI3 Kinase Inhibitor - Taselisib Companion Diagnostic Assay - Product Status
PI3 Kinase Inhibitor - Taselisib Companion Diagnostic Assay - Product Description
PI3 Kinase/mTOR Dual Inhibitor - GDC-0980 Companion Diagnostic Assay - Product Status
PI3 Kinase/mTOR Dual Inhibitor - GDC-0980 Companion Diagnostic Assay - Product Description
Pictilisib - GDC-0941 Companion Diagnostic Assay - Product Status
Pictilisib - GDC-0941 Companion Diagnostic Assay - Product Description
Quilizumab (Anti-M1 prime Mab) Companion Diagnostic Assay - Product Status
Quilizumab (Anti-M1 prime Mab) Companion Diagnostic Assay - Product Description
Ranibizumab Companion Diagnostic Assay - Product Status
Ranibizumab Companion Diagnostic Assay - Product Description
Tocilizumab Companion Diagnostic Assay - Product Status
Tocilizumab Companion Diagnostic Assay - Product Description
Tofogliflozin Companion Diagnostic Assay - Product Status
Tofogliflozin Companion Diagnostic Assay - Product Description
Vemurafenib Companion Diagnostic Assay - Thyroid Cancer - Product Status
Vemurafenib Companion Diagnostic Assay - Thyroid Cancer - Product Description
Vismodegib Companion Diagnostic Assay - Product Status
Vismodegib Companion Diagnostic Assay - Product Description
Genentech Inc, Key Employees

LIST OF FIGURES

Genentech Inc Pipeline Products by Equipment Type
Genentech Inc Pipeline Products by Development Stage

COMPANIES MENTIONED

Tesaro Inc
Novartis Vaccines and Diagnostics Inc
Notal Vision Inc
NewLink Genetics Corp
Merck Serono SA
MedImmune LLC
MediGene Inc
Janssen Biotech Inc
Enhanced Vision, Inc.
Eli Lilly and Company
CASI Pharmaceuticals Inc
Cascadian Therapeutics Inc
Bristol-Myers Squibb Company
Biogen Inc
Atara Biotherapeutics Inc
Amgen Inc
Accacia International
Skip to top


Ask Your Question

Genentech Inc - Product Pipeline Analysis, 2016 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: